Sinopep is one of the leading peptide API manufacturers with extensive experience and an proven track record in supporting our worldwide customers' supply network ranging from Pre-clinical, clinical to commercial. One significant differentiator is that sinopep could support a wide variety of scope and scale of projects, not limited by scale.

Sinopep is one of very few companies in the world capable of manufacturing peptide APls at ton quantities annually. Our automated peptide synthesizers ranges from 20L to 2,000L in volume. Sinopep’s large scale peptide manufacturing capacity and capability also includes equipment for hybrid SPPS/LPPS approach, preparative HPLC, lyophilization, as well as spray drying for high throughput peptide synthesis, purification and isolation.

With the help of Industry 4.0 technologies, we have modernized our platforms through digitization, automation, robotics, and computing advancements.  It dramatically increased the efficiency, flexibility, and scalability of our large-scale peptide manufacturing.

Sinopep's oligonucleotide technology platforms are equipped with state-of-the-art technologies including Cytiva OligoSynt/OligoPilot solid phase synthesizer, and AKTAAvant/Process purification equipment which could produce API from miligram to kilogram scale. These platforms could provide our customers full CRDMO services covering development and manufacturing for both drug substance and drug product from pre-clinical through clinical stages.

Sinopep has invested in building process development capabilities and manufacturing capacity over the last 20 years to support your drug development and supply needs from preclinical to commercial. With our global standard quality system, we are uniquely positioned to be your strategic manufacturing partner for reliable, cost effective long-term supplies of your intermediates and APIs from a few grams to metric tons. With hundreds of modern reactors ranging from 100L to 10,000L, our "end-to-end" production platform in Jiande site offers you short production lead time and ample flexibility.